Kudos to our long-standing client, the Edmond de Rothschild Foundation (Israel), for signing an agreement to donate NIS 180 million to the building of a research institute as part of Bar-Ilan University’s Faculty of Medicine expansion project.
This project is a significant part of the foundation’s huge NIS 1 Billion contribution over the last decade to benefit Israeli society, promote and develop highereducation in Israel, and strengthen the Israeli medical system in battling the Coronavirus.
Adv. Menachem Tulchinsky, Managing Partner, Adv. Galia Suesskind-Spiegel, Partner and Head of the Real Estate Department, and Adv. Karin Abramovich supported the fund on this project.
To read an article on the subject, click here (Hebrew).
Congratulations to our long-standing clients, Teva Pharmaceuticals and S.L.E, one of Israel’s leading pharma-logistics providers, who are playing central roles in the nation-wide distribution of the covidー19 vaccine, as part of the State of Israel’s operation to vaccinate Israeli citizens against COVID-19.
Teva and S.L.E will be transporting and storing the vaccines at their logistics centers located in Shoham and Kfar Saba.
We are proud to support these companies in all areas of their activity, including the significant sale and lease back transaction of the Shoham Logistics Center, which was signed last year!
Click here for press coverage (Hebrew).
We are hiring!
Tulchinsky, Stern, Marciano, Cohen, Levitsky & Co. are looking for an IT and innovation lawyer, with three years’ relevant commercial experience at a leading law firm.
You can send CVs to netal@tslaw.co.il
Our IT and Innovation department supports leading businesses in IT transactions and acts for financial institutions and other major entities in Israel in high-profile projects at the cutting-edge of technology, such as digital banking, smart contracts, blockchain-based networks, FinTech, and cloud banking.
As a vibrant and growing sector, this field is rich in complexity and we are looking for a highly motivated team player with a strong interest in technology, mother-tongue English, previous commercial experience and good interpersonal skills.
Highcon completes a $45 million IPO on the Tel Aviv Stock Exchange.
Senior partners Doron Stern and David Cohen assisted the offering. Doron represented JVP one of the two controlling shareholders of the Company, and David advised the board of directors.
Congratulations to Highcon and its tireless CEO Shlomo Nimrodi, to JVP and its visionary partners Fiona Darmon and Erel Margalit, as well as to our colleagues from Shibolet & Co. who performed the legal work in record pace and quality.
To read an article on the subject, click here (Hebrew).
We are pleased to advise our client, Bank Hapoalim, on another innovative and groundbreaking project to launch a network of blockchain-based digital guarantees, in collaboration with Microsoft Israel and TCS.
The network is a unique and safe solution for all entities issuing guarantees in Israel and for the beneficiaries of those guarantees and is changing the current situation – in which guarantee beneficiaries are forced to contact issuers directly.
Bank Hapoalim was represented in the transaction by partner Alon Tabak, along with Adv. Ilan Sapir and Adv. Ben Baharav from our IT and Innovation Department.
Click here for news coverage on the subject (Hebrew).
According to an amendment to the Economic Assistance Program Law, employees, and their children, who are forced to isolate will be entitled to an isolation fee from their employer.
From February 1, 2021, an employer will be able to submit an indemnity application to the National Insurance Institute for the isolation fee it pays out between October, 2020 and March 31, 2021.
Partner Michal Markovitz-Blachar, Head of our Labour Law Department, along with Adv. Ariel Shanon and intern Idan Zur, conducted a comprehensive review of the amendment’s implications on both employers and employees.
To read the review, click here (Hebrew).
Congratulations to our client, EyeWay Vision Ltd., which has successfully completed an internal investment round.
EyeWay develops innovative technology in the field of augmented reality.
Adv. Gershon (Glenn) Shalom-Winter, a partner in our High-Tech and Venture Capital Funds Department, and Adv. Karin Abramovich from our Corporate and Securities Department represented EyeWay.
Congratulations to our longtime clients JVP – Jerusalem Venture Partners, who led investment in the amount of $27 million in the Israeli startup company ControlUp!
Adv. Doron Stern, Partner, along with Adv. Aaron Shaw and Adv. Ruth Furmanski from our firm’s High – Tech department, accompanied JVP in completing this successful investment.
The Privacy Protection Authority has recently published draft recommendations for managing the use of applications for transferring money between individuals and for payment in businesses in relation to terms of privacy, consent, and information security.
Among other things, the Authority recommended the principles of the right to privacy and set out actions to be taken.
Attorneys Avital Sela, Miriam Sade Fischer, and Karin Abramovich from our firm’s Privacy and Information Security team, together with intern Chen Shaham, conducted a review of the Authority’s recommendations and the steps that business owners and developers should take accordingly.
Click here for the full article (Hebrew).
The Privacy Protection Authority has recently published a draft position paper regarding the appointment of a Privacy Protection Commissioner in organizations and invited the public to submit their comments.
Among other things, the Authority recommended relevant training for the commissioner, outlining his duties in detail.
Adv. Avital Sela, Adv. Miriam Sade Fischer and Adv. Karin Abramovich from our firm’s Privacy and Data Protection team, together with intern Chen Shaham, conducted a comprehensive review of the paper and the steps that organizations should take accordingly.
Click here for the full review (Hebrew).
We are deeply grateful to our clients for their feedback in the latest ITR’s World Tax and World Transfer Pricing Rankings for 2020 – just published.
We were ranked for General Corporate Taxes, Real Estate Taxation, and, for the first time in this guide, World Transfer Pricing.
ITR – International Tax Review – researches the world’s leading and most respected tax advisors across 74 jurisdictions each year.
We are proud to be ranked by the international ranking guide, IFLR1000 2020 edition, in the field of mergers and acquisitions!
Managing Partner, Menachem Tulchinsky, and Partner David Cohen from our Corporate and Securities Department, ranked as highly regarded lawyers in the field.
Proud to have our firm recognized and ranked by the 2020 #BDi rankings guide. Our firm was recognized among the leading law firms in Israel in Hi-Tech, Health, International Commercial, Israeli Commercial, Litigation, Real Estate, Tax, White Collar, Labour Law and Enviroment!
Adv. Uri Nesher, Aaron Shaw and Ruth Furmanski of our firm represented Jerusalem Venture Partners (JVP) in a $7 million Seed financing round led by JVP, in GreenEye, an Israeli crop protection startup, together with investments from Syngenta Ventures (the world’s largest crop chemical producer), 2B Angels, One Way venture, Panache Ventures Techstars, and Hyperplane Venture Capital. Greeneye utilizes artificial intelligence and deep learning technologies to revolutionize the weed control process in agriculture, transitioning from the current practice of wasteful spraying of herbicides to accurately detect and spray weeds in real-time. See Article
Kudos to our client, Jerusalem Venture Partners (JVP) for being there, during these times of uncertainty for startups, for its portfolio companies, which raised $200M during the pandemic, with JVP leading the majority of the investments. Our firm is proud to have represented JVP in these transactions. Team members included Adv. Doron Stern, Uri Nesher, Benjamin Bekkerman, Aaron Shaw and Ruth Furmanski. See Article
Adv. Uri Nesher of our firm represented Jerusalem Venture Partners (JVP) in a $10.5 million financing round in Source Defense, with investments by new investor Capital One Ventures, alongside existing investors – JVP, Allegis Cyber, Global Brain and NightDragon who also participated in the round. Source Defense is an Israeli website security startup which develops cloud-based software for automatically monitoring and detecting vulnerabilities on third-party applications used on websites. See Article
Adv. Uri Nesher of our firm represented Jerusalem Venture Partners (JVP) in a $21 million financing round in Nanit, led by existing investors JVP, Upfront Ventures, RRE Ventures, and Rho. Nanit is a US-Israeli startup which developed a machine learning and computer vision-based camera that monitors and analyzes a baby’s sleep patterns in real-time, offering sleep insights, behavioral analysis, expert advice, and nightly video summaries. See Article
Adv. Galia Suesskind-Spiegel and Adv. Tal Levy of our Real Estate Department represented the Caesarea Assets Corporation in its transaction with Intel unit “Habana Labs”. Habana Labs will lease approximately 8,000 sqm in the Ofek 14 building in the Granit Campus, which is being constructed by the Corporation in the Caesarea Business Park. See Article
Adv. Uri Nesher of our firm represented Jerusalem Venture Partners (JVP) in a $15 million Series B financing round led by JVP, in Secret Double Octopus, an Israeli based passwordless authentication startup, together with investments from Tokyo-based Sony Financial Ventures, telecommunications provider KDDI Corporation, Japanese venture firm Global Brain Corp, and existing investors Benhamou Global Ventures (BGV), European venture capital firm Iris Capital, Liberty Media Corporation, and early stage investor Yaniv Tal. See Article
Adv. Uri Nesher, Aaron Shaw and Ruth Furmanski of our firm represented Jerusalem Venture Partners (JVP) in a $15 million Series B financing round led by JVP, in Israeli food-tech company InnovoPro, which has developed a 70% chickpea protein concentrate, and products based on its protein have been launched in the United States, Europe and Israel. Additional investors in this round included CPT Capital, one of the premier global food tech investors and additional strategic and financial investors. See Article
We are delighted and proud of our firm being ranked in eight categories in the 2020 Legal 500 edition and of 15 of our firm’s advocates being personally ranked and recommended!
Warm congratulations to Menachem (Tuli) Tulchinksy, Doron Stern, Isaac Marciano, David Cohen, Amir Levitski, Alon Tabak Aviram, Uri Barak, Uri Corb, Assaf Benmelech, Michal Markovitz-Blachar, Uri Nesher, Amit Hirsch, Galia Suesskind Spiegel, Elad Mirvis and Liat Sass.
Adv. Galia Suesskind-Spiegel and Adv. Tal Levy of our Real Estate Department, represented our firm’s long time client, the Caesarea Assets Corporation Edmond Benjamin de Rothschild, its engagement with Decathlon France Corporation, for the building and lease of an advanced logistics center which will be built at the Caesarea Smart Business and Industrial Park on a 35,000 sqm parcel of land. The establishment of the logistics center is estimated at NIS 60 million, encompassing 18,000 sqm which will include storage units and office space. See Article
We are proud to have taken part in one of the major projects in the IT and Banking field in Israel: Adv. Alon Tabak Aviram and Adv. Ben Baharav represented the first Israeli Digital Bank in its engagement with TCS – a member of TATA Group, that will develop and supply the bank’s technological infrastructure as part of the establishment of a Banking Services Bureau in Israel. See Article
Extremely proud of our client Plaqless Ltd. for its part in the new breakthrough technology designed to revolutionize oral health introduced by Colgate. The Colgate® Plaqless Pro Smart Electric Toothbrush just won the Innovation Award at the CES in Las Vegas in advance of a 2020 launch. Congrats to Colgate and the entire Plaqless team!! Plaqless are represented by Adv. Alon Tabak Aviram and Adv. Tamar Nesher. See Article
Together with the New Year, we are proud to be celebrating our Firm’s 25th Anniversary!
Grateful to all those who have been with us over the years. Here’s to many more!
Adv. Uri Barak and Adv. Stav Kedar of our firm represented SonicWall, a US cyber company, in a $10M financing round led by Sonicwall, in Perimiter 81, which develops technology for secure remote access to enterprise networks. See Article
Adv. Uri Nesher and Adv. Naomi Vestfrid of our firm represented Jerusalem Venture Partners (JVP) and the Israel National Initiative Association (ii2020), as part of ILAB group, composed of JVP, Israeli communications giant Mellanox Technologies Ltd., ii2020, and Haifa’s business development center Mati Haifa, in their winning bid in the competitive process initiated by the Israel Innovation Authority to develop technological innovation in Haifa. The group will receive a NIS 25 million grant for 4 years from the Israel Innovation Authority and will match that amount, reaching NIS 50 million, with the aim of promoting and integrating extensive technological entrepreneurial activity in Haifa, in the areas of digital health, energy, environment, advanced industry 4.0 and smart transport, and will also establish dedicated workspaces and acceleration programs. See Article
Adv. Uri Nesher of our firm represented Jerusalem Venture Partners (JVP) in a $10 million round of financing led by Flint Capital, in Loom Systems, the creator of the leading predictive AIOps platform which detects IT issues before traditional monitoring tools, by capturing logs, metrics, alerts and events, correlating and predicting IT issues before the business is impacted, while also delivering the insights and knowledge the frontline needs to resolve them quickly. See Article
Adv. Galia Suessking Speigel and Adv. Tal Levy of our firm represented our long time client, the Caesarea Assets Corporation in its transaction with Max Management Israel Ltd. (Max Stock), controlled by APAX Fund for the lease by Max Stock of approximately 10,000 sqm in the “HaEshel” Logistics Center at the Caesarea Business Park.
Adv. Gershon Shalom Winter, Adv. Tamar Nesher and Adv. Karin Abramovitz of our Firm represented Advanced Dicing Technologies Ltd. – an Israeli based electronics dicing equipment company in its acquisition by Chinese investment fund Neng Yang. See Article
Our firm represented Amot Investments Ltd. in a Sale and Leaseback transaction, in which Amot acquired the rights of Teva Pharmaceutical Industries Ltd. on an area of approximately 77 dunam located in the Hevel Modiin Industrial Area, together with the buildings on them and building rights, in exchange for a sum of approximately NIS 450,000,000. One of the largest and most advanced logistics centers in the world for storage and transportation of medical equipment is built on the land.
Within the framework of the transaction, Amot signed a lease agreement with Salomon Levin Elstein Ltd. (a subsidiary of Teva) (“Sala”), according to which Sala leases the land and the buildings on it for a period of 10 years, together with options to extend the lease, in exchange for an annual rent of approximately NIS 22,000,000.
The transaction was led by partners Menachem Tulchinsky, Galia Suesskind-Spiegel, Elad Mirvis, and Adv. Mayan Miller. See Article.
We are proud to have taken part in one of the main innovative projects in the IT and Banking field in Israel. Adv. Alon Tabak Aviram and Adv. Ilan Sapir of our IT Department represented the Digital Bank in its engagement in the Ministry of Finance’s tender to establish a Services Bureau. In addition, Adv. Alon Tabak Aviram and Adv. Ilan Sapir are representing the Digital Bank in its engagement with its future Core-Systems and IT Supplier.
Our firm, supports and represents the Caesarea Edmond Benjamin De Rothschild Assets Corp. (2001) Ltd., in all areas of its activity, and recently, Adv. Galia Suesskind Spiegel and Adv. Mayan Miller of our Real Estate Department, represented the company in its transaction with Mazor Robotics Ltd., for the lease by Mazor of approximately 5,200 sqm in the “Ofek 12” buildings of the Caesarea Smart Business Park.
Adv. Alon Tabak Aviram and Adv. Ilan Sapir of our IT Department represented Bank Mizrahi Tefahot in a transaction for implementation of a new securities market core system. See Article
Congratulations to our customers, the Caesarea Development Company, on signing a 5-year lease agreement with an option to extend, with Mazor Robotics (owned by the technology company Medtronic), for NIS 13 million.
The transaction was led by Partner Galia Suesskind-Spiegel, Head of the Real Estate Department, together with Adv. Mayan Miller. See Article.
Adv. Menachem Tulchinsky, Adv. Amit Hirsch and Adv. Shira Efrati of our firm represented Teva Pharmaceutical Industries Ltd. in a motion for discovery prior to submission of a motion for filing a derivative action filed against Teva, under a claim that retirement grants paid by Teva to its former senior office holders are inconsistent with the Company’s Compensation Policy and the law. The District Court rejected the motion for discovery and accepted Teva’s claims in full, imposing legal and attorneys’ fees on the petitioner.
Our Firm supported the establishment of a one-of-a-kind archeological tourist project in Caesarea, which was officially opened in a ceremony attended by President Reuven Rivlin and Baroness Ariane de Rothschild. The opening was preceded by five years of excavation, conservation and reconstruction at great investment by the Edmond De Rothschild Foundation and performed by the Caesarea Edmond Benjamin De Rothschild Corporation, together with the Israel Antiques Authority and the Israel Nature and Parks Authority.
Adv. David Cohen and Adv. Lior Etgar of our firm represented Biond Biologics Ltd in a $17 million financing round led by Israel Biotech Fund and Harel Insurance & Finance Group, with participation of Celgene Corporation, (NASDAQ: CELG), the Japanese-Israeli fund, SBI JI Innovation Fund and existing investors. Biond Biologics is a drug discovery and development company focused on the field of immunotherapy, combining excellent science and out-of-the-box innovative thinking. See Article
Adv. Uri Nesher, Adv. Hila Faber and Adv. Daniel Shil Szriber of our firm represented Jerusalem Venture Partners (JVP) in a $22.5 million financing round led by JVP in Quali Systems, together with investments from existing investors Dell Ventures, Kreos Capital, Evergreen Ventures, Gemini Israel Ventures, and ORR Partners. Quali Systems is a software company focused on automation and orchestration software to deliver environments-as-a-service for digital transformation initiatives aligned with cloud, DevOps and Security. See Article
Adv. Galia Suesskind-Spiegel and Adv. Mayan Miller of our firm represented Caesarea Assets Corporation in the signing of a huge deal with China’s Fosun Pharmaceutical’s Israel-based subsidiary for a 10-year lease of approximately 11,000 m2 of the entire “Ofek 15” building being built by Caesarea Assets Corporation near the Caesarea train station. See Article
Uri Nesher of our firm represented Jerusalem Venture Partners (JVP) founder and chairman Erel Margalit, in an investment in Israeli foodtech start-up InnovoPro, the developer of a revolutionary technology designed to extract a 70% protein concentrate from chickpeas, as part of a $4.25M financing round led by the investment arm of Migros, Switzerland’s largest retailer, with additional investments by Bits x Bites, a Chinese VC that invests in food tech, Ran Tuttnauer, ID Capital from Singapore and Yara ventures from Spain. See Article
Adv. Uri Nesher and Adv. Aaron Shaw of our firm represented Jerusalem Venture Partners (JVP) in a $2 million seed financing round led by JVP in blockchain cybersecurity startup Valid Network Ltd., which develops enterprise software for securing smart contracts capable of identifying code vulnerabilities, possible loopholes, changes between versions, and abnormal activity to prevent fraud. Valid will also join JVP’s cybersecurity incubator, JVP Cyber Labs. See Article
Adv. Daniel Chinn and Adv. Mati Rosenbaum of our firm represented Hetz Ventures and Vertex Ventures Israel in a $7 Million seed funding round in Trigo Vision, an Israeli retail automation startup which uses in-store ceiling-mounted cameras to identify items picked by customers and create a no-checkout shopping experience. See Article
Adv. Gershon Shalom-Winter and Adv. Lana Tavor of our office represented RedHill Biopharma in negotiating a co-promotion agreement with Napo Pharmaceuticals, Inc., a subsidiary of Jaguar Health (NASDAQ: JAGX), granting RedHill the exclusive right to co-promote Mytesi® (an FDA-approved anti-diarrheal prescription drug indicated for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on anti-retroviral therapy) in the U.S. to certain gastroenterologists and primary care physicians for the approved indication in people living with HIV/AIDS. See Press Release
Adv. Menachem Tulchinsky and Adv. Elad Mirvis of our firm represented the Edmond Benjamin de Rothschild Caesarea Foundation in the negotiation and consummation of the new agreement between the State of Israel and the Foundation, in the framework of which, inter alia, the cooperation agreement between the parties was extended until 2032, the Foundation will donate substantial amounts of up to NIS 1 billion for higher education projects in Israel over the next few years, and will continue to support the development of the Or-Yam neighborhood in Or Akiva in cooperation with the Israeli Land Authority.
Adv. Doron Stern, Adv. Benjamin Bekkerman and Adv. Mati Rosenbaum of our firm represented Optimove, makers of the Science-first Relationship Marketing Hub, in its acquisition of the DynamicMail business from PowerInbox, a leader in email real-time personalization and dynamic subscriber engagement. See Article
Adv. David Cohen, Adv. Gershon (Glenn) Shalom-Winter, Adv. Uri Barak, Adv. Alon Karniel, Adv. Elad Mirvis, Adv. Lior Etgar and Adv. Stav Kedar, with the assistance of interns Karin Abramovich and Eden Halpert, represented Orbotech in its acquisition by KLA-Tencor Corporation (NASDAQ: KLAC) in exchange for cash and stock which values Orbotech at an equity value of approximately $3.4 billion. See Press Release
Adv. Doron Stern of our firm talk on Privacy & Privatization at the recent TEDx BGU event at Ben Gurion University. For the video click here
Adv. Menachem Tulchinsky, Adv. Uri Barak, Adv. Elad Mirvis, Adv. Lior Etgar and Adv. Alon Nahear of our firm represented Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) in its $4.5 billion debt offering for qualified institutional investors under Rule 144A of the U.S. Securities Act and to Non-U.S. persons pursuant to Regulation S under the U.S. Securities Act. To read more about the offering – click here
Adv. Uri Nesher and Adv. Aaron Shaw of our firm represented Jerusalem Venture Partners (JVP) in its investment as part of a $21 million series C funding round, lead by JVP and Arrowroot Capital in Leadspace – who developed the first B2B Audience Management Platform for Marketing and Sales. See press release
Adv. Daniel Chinn and Adv. Saar Binyamin of our firm represented Lemonade Inc. in its recent $120,000,000 Series C financing round. See Press Release
Adv. Gershon Shalom-Winter and Adv. Lior Etgar of our firm represented an Israeli Hi-Tech company, specializing in laser and optical amplifiers, in an investment round in which the company raised approximately $14 million.
Adv. David Cohen, Adv. Lior Etgar and Adv. Aner Lev of our firm represented an Israeli biomed company which specializes in life science research and development in the field of cancer and autoimmune disorders, in its Series A Preferred Share investment round in which the company raised approximately $4.5 million.
Adv. Alon Tabak Aviram, Adv. Dafna Achiam Tal, Adv. Ilan Sapir and Adv. Alon Nahear of our firm represented Israeli company Nextine Ltd., a leading provider of industrial cyber security solutions, in its acquisition by Honeywell corporation for approximately $35 million. See press release
עדכוני חקיקה ופסיקה בדיני עבודה – יולי 2017 לחץ/י כאן למזכר
Adv. Daniel Chinn and Adv. Hila Faber of our firm represented Aleph VC in its investment as part of a $4 million seed round, with additional investment from XL Innovate, in Israeli rel time political risk evaluaion company Geoquant.
Adv. Daniel Chinn and Adv. Hila Faber of our firm represented Qumra Capital (Qumra) in its investment as part of a $22 million funding round led by Qumra, with additional investment from BRM Group and other European investors, in Israeli resort suite booking company Sweet Inn. See press release
Adv. Uri Nesher and Adv. Mati Rosenbaum of our firm represented Jerusalem Venture Partners (JVP) in its investment as part of a $6 million funding round led by JVP, with additional investment from Meron Capital and 31Ventures Global Innovation Fund, in Loom Systems Ltd., an Israeli AI-powered log analysis software platform developer. See press release
Adv. Gershon Shalom-Winter of our firm represented RedHill BioPharma Ltd. (NASDAQ/TASE: RDHL) in connection with the acquisition from Entera Health Inc. of exclusive rights in the U.S. to EnteraGam®, a commercially-available medical food, comprising a serum-derived bovine immunoglobulin/protein isolate (SBI), which must be administered under medical supervision. RedHill BioPharma is a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal (GI) and inflammatory diseases and cancer. See Press Release
Adv. David Cohen, Adv. Uri Barak and Adv. Lior Etgar of our firm represented Israeli automatic print inspection systems company – Advanced Vision Technology Ltd. (XETRAL VSJ) in its acquisition by US technology company Danaher Corp for $100 million. AVT is the only Israeli company listed for trade on the Frankfurt Stock Exchange. See press release
OpenValley עו”ד גליה זיסקינד שפיגל ועו”ד מעין מילר ממשרדנו ייצגו את החברה לנכסי קיסריה, במו”מ על השכרת כל מבנה אופק 11 שפארק העסקים של קיסריה, לחממה הטכנולוגית
Adv. Gershon Shalom-Winter of our firm represented ConTIPI Medical Ltd., an Israeli developer of non-invasive, disposable solutions for pelvic floor dysfunction in women, in its Series A Preferred Share investment round in which it has raised almost $2,000,000.
Adv. Gershon Shalom-Winter of our firm represented RedHill BioPharma (NASDAQ/TASE: RDHL) in connection with an exclusive co-promotion agreement with a subsidiary of Concordia International Corp. (NASDAQ: CXRX) (TSX: CXR), an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs, granting RedHill certain U.S. promotion rights for Donnatal. See Press Release
© All rights reserved to Tulchinsky Stern Marciano Cohen Levitski & Co |
Terms of use
|
Design and development
Beaver Global
Congratulations to our longtime clients JVP – Jerusalem Venture Partners (including the JVP food tech arm) who led another investment in the startup company Innovopro, which develops chickpea-based proteins as a sustainable food product, in the amount of USD 18.5 million, as part of JVP’s vision to promote and develop the food tech industry.
Partner Uri Nesher, along with Adv. Aaron Shaw and Adv. Ruth Furmanski from our firm’s High – Tech department, accompanied JVP in completing this successful investment, and were part of the Israeli counsel team advising the Netherlands based Rabo Food & Agri Innovation Fund, part of Rabobank’s investment arm, which also participated in the investment.
For news coverage on the subject, Click here.